Literature DB >> 33998543

PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Fang Du1, Qing Yu1, Shirley ShiDu Yan1.   

Abstract

BACKGROUND: Mitochondrial dysfunction, bioenergetic deficit, and extensive oxidative stress underlie neuronal perturbation during the early stage of Alzheimer's disease (AD). Previously, we demonstrated that decreased PTEN-induced putative kinase 1 (PINK1) expression is associated with AD pathology in AD-affected human brains and AD mice.
OBJECTIVE: In the present study, we highlight the essential role of PINK1 in AD-relevant mitochondrial perturbation and neuronal malfunction.
METHODS: Using trans-mitochondrial "cybrid" (cytoplasmic hybrid) neuronal cells, whose mitochondria are transferred from platelets of patients with sporadic AD, we observed the effect of PINK1 in neuronal-like differentiation and synaptogenesis and mitochondrial functions.
RESULTS: In AD cybrid cells, the downregulation of PINK1 is correlated to the alterations in mitochondrial morphology and function and deficit in neuronal-like differentiation. Restoring/increasing PINK1 by lentivirus transduction of PINK1 robustly attenuates mitochondrial defects and rescues neurite-like outgrowth. Importantly, defective PINK1 kinase activity fails to reverse these detrimental effects. Mechanistically, AD cybrid cells reveal a significant decrease in PINK1-dependent phosphorylated mitofusin (Mfn) 2, a key mitochondrial membrane protein that participates in mitochondrial fusion, and an insufficient autophagic activity for the clearance of dysfunctional mitochondria. Overexpression of PINK1, but not mutant PINK1 elevates phosphorylation of Mfn2 and autophagy signaling LC3-II. Accordingly, PINK1-overexpressed AD cybrids exhibit increases in mitochondrial length and density and suppressed reactive oxygen species. These results imply that activation of PINK1 protects against AD-affected mitochondrial dysfunction and impairment in neuronal maturation and differentiation.
CONCLUSION: PINK1-mediated mitophagy is important for maintaining mitochondrial health by clearance of dysfunctional mitochondria and therefore, improves energy homeostasis in AD.

Entities:  

Keywords:  Alzheimer’s disease; PINK1; cybrid cells; mitochondrial dysfunction; mitophagy

Mesh:

Substances:

Year:  2021        PMID: 33998543      PMCID: PMC9004622          DOI: 10.3233/JAD-210095

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  52 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells.

Authors:  Liliana Rojas-Charry; Mark R Cookson; Andrea Niño; Humberto Arboleda; Gonzalo Arboleda
Journal:  Neurotoxicology       Date:  2014-05-02       Impact factor: 4.294

4.  Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Nairita Roy; Lewis Hutfles; Jeffrey M Burns; Elias K Michaelis; ShiDu Yan; Sandra M Cardoso; Russell H Swerdlow
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

Review 5.  Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise.

Authors:  J P Blass; R K Sheu; G E Gibson
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 6.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

7.  Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.

Authors:  Sandra M Cardoso; Isabel Santana; Russell H Swerdlow; Catarina R Oliveira
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

Review 8.  Synergy between amyloid-β and tau in Alzheimer's disease.

Authors:  Marc Aurel Busche; Bradley T Hyman
Journal:  Nat Neurosci       Date:  2020-08-10       Impact factor: 24.884

9.  Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.

Authors:  Qichao Huang; Lei Zhan; Haiyan Cao; Jibin Li; Yinghua Lyu; Xu Guo; Jing Zhang; Lele Ji; Tingting Ren; Jiaze An; Bingrong Liu; Yongzhan Nie; Jinliang Xing
Journal:  Autophagy       Date:  2016-04-28       Impact factor: 16.016

Review 10.  Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis.

Authors:  Anushka Chakravorty; Cuckoo Teresa Jetto; Ravi Manjithaya
Journal:  Front Aging Neurosci       Date:  2019-11-20       Impact factor: 5.750

View more
  3 in total

Review 1.  Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches.

Authors:  Arnaud Mary; Fanny Eysert; Frédéric Checler; Mounia Chami
Journal:  Mol Psychiatry       Date:  2022-06-03       Impact factor: 15.992

2.  Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer's disease.

Authors:  Fang Du; Qing Yu; Nicholas M Kanaan; Shirley ShiDu Yan
Journal:  Hum Mol Genet       Date:  2022-08-17       Impact factor: 5.121

Review 3.  A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.

Authors:  Huiyi Chen; Feng Chen; Ying Jiang; Lu Zhang; Guizhen Hu; Furong Sun; Miaoping Zhang; Yao Ji; Yanting Chen; Gang Che; Xu Zhou; Yu Zhang
Journal:  Front Aging Neurosci       Date:  2022-05-20       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.